Literature DB >> 8626550

Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase.

M M McLaughlin1, S Kumar, P C McDonnell, S Van Horn, J C Lee, G P Livi, P R Young.   

Abstract

CSBP p38 is a mitogen-activated protein kinase that is activated in response to stress, endotoxin, interleukin 1, and tumor necrosis factor. Using a catalytically inactive mutant (D168A) of human CSBP2 as the bait in a yeast two-hybrid screen, we have identified and cloned a novel kinase which shares approximately 70% amino acid identity to mitogen-activated protein kinase-activated protein kinase (MAPKAP kinase)-2, and thus was designated MAPKAP kinase-3. The binding of CSBP to MAPKAP kinase-3 was confirmed in vitro by the precipitation of epitope-tagged CSBP1, CSBP2, and CSBP2(D168A) and endogenous CSBP from mammalian cells by a bacterially expressed GST-MAPKAP kinase-3 fusion protein and in vivo by co-precipitation of the epitope-tagged proteins co-expressed in HeLa cells. MAPKAP kinase-3 was phosphorylated by both CSBP1 and CSBP2 and was then able to phosphorylate HSP27 in vitro. Treatment of HeLa cells with sorbitol or TNF resulted in activation of CSBP and MAPKAP kinase-3 and activation of MAPKAP kinase-3 could be blocked by preincubation of cells with SB203580, a specific inhibitor of CSBP kinase activity. These data suggest that MAPKAP kinase-3 is activated by stress and cytokines and is a novel substrate of CSBP both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626550     DOI: 10.1074/jbc.271.14.8488

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  77 in total

Review 1.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

2.  Activation of p38 mitogen-activated protein kinase by norepinephrine in T-lineage cells.

Authors:  Melissa D Lajevic; Samia Suleiman; Rhonna L Cohen; Donald A Chambers
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

Review 3.  The ERK cascade: a prototype of MAPK signaling.

Authors:  Hadara Rubinfeld; Rony Seger
Journal:  Mol Biotechnol       Date:  2005-10       Impact factor: 2.695

4.  Feedback control of the protein kinase TAK1 by SAPK2a/p38alpha.

Authors:  Peter C F Cheung; David G Campbell; Angel R Nebreda; Philip Cohen
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

5.  Both binding and activation of p38 mitogen-activated protein kinase (MAPK) play essential roles in regulation of the nucleocytoplasmic distribution of MAPK-activated protein kinase 5 by cellular stress.

Authors:  Ole Morten Seternes; Bjarne Johansen; Beate Hegge; Mona Johannessen; Stephen M Keyse; Ugo Moens
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

6.  Stress-induced regulation of eukaryotic elongation factor 2 kinase by SB 203580-sensitive and -insensitive pathways.

Authors:  Axel Knebel; Claire E Haydon; Nick Morrice; Philip Cohen
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

Review 7.  The potential of p38 MAPK inhibitors to modulate periodontal infections.

Authors:  Keith L Kirkwood; Carlos Rossa
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

8.  Hydrogen sulfide is an endogenous stimulator of angiogenesis.

Authors:  Andreas Papapetropoulos; Anastasia Pyriochou; Zaid Altaany; Guangdong Yang; Antonia Marazioti; Zongmin Zhou; Mark G Jeschke; Ludwik K Branski; David N Herndon; Rui Wang; Csaba Szabó
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-02       Impact factor: 11.205

9.  Heat-shock protein-25/27 phosphorylation by the delta isoform of protein kinase C.

Authors:  E T Maizels; C A Peters; M Kline; R E Cutler; M Shanmugam; M Hunzicker-Dunn
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

10.  Gene expression phenotype in heterozygous carriers of ataxia telangiectasia.

Authors:  Jason A Watts; Michael Morley; Joshua T Burdick; Jennifer L Fiori; Warren J Ewens; Richard S Spielman; Vivian G Cheung
Journal:  Am J Hum Genet       Date:  2002-09-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.